Mylan (MYL) and Aspen Report Launch of Generic Busulfex Injection
Tweet Send to a Friend
Mylan N.V. (NASDAQ: MYL) and its partner, Aspen, today announced the U.S. launch of Myleran (busulfan) Injection, 60 mg/10 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
